Intra-arterial vasodilator use during endovascular therapy for acute ischemic stroke might improve reperfusion rate

Ziad M K El-Zammar, Julius Gene S Latorre, Dongliang Wang, Shyama Satyan, Elwaleed Elnour, Adham Kamel Elsayed Elokda, Ashok Devasenapathy, Yahia M. Lodi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Treatment of acute ischemic stroke (AIS) is an evolving field. New treatment options are still needed in order to achieve greater success rates for arterial recanalization. Intra-arterial therapy (lAT) is an option for AIS patients who are not good candidates for intravenous (i.v.) recombinant tissue plasminogen activator (rt-PA) or where it has failed. While good data establishing the role of IAT in AIS management are lacking, the potential clinical efficacy of IAT is based on the premise that recanalization and reperfusion may result in better clinical outcome. Although lAT recanalization and reperfusion rates of large vessel occlusion are much higher than they are for i.v. rt-PA, IAT's radiological efficacy is still far from perfect. Vasodilator use during IAT for AIS may increase the recanalization and reperfusion rates of such therapy. In this report, we describe the radiographic and clinical outcomes in a cohort of AIS patients who received intra-arterial (i.a.) vasodilators during IAT and summarize the role of i.a. vasodilators in the process of recanalization and reperfusion.

Original languageEnglish (US)
Pages (from-to)134-140
Number of pages7
JournalAnnals of the New York Academy of Sciences
Volume1268
Issue number1
DOIs
StatePublished - Sep 2012
Externally publishedYes

Fingerprint

Vasodilator Agents
Reperfusion
Stroke
Tissue Plasminogen Activator
Therapeutics
Implicit Association Test
Therapy
Efficacy

Keywords

  • Acute ischemic stroke
  • Endovascular
  • Fibrinolysis
  • Intra-arterial
  • Vasdodilators

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

El-Zammar, Z. M. K., Latorre, J. G. S., Wang, D., Satyan, S., Elnour, E., Kamel Elsayed Elokda, A., ... Lodi, Y. M. (2012). Intra-arterial vasodilator use during endovascular therapy for acute ischemic stroke might improve reperfusion rate. Annals of the New York Academy of Sciences, 1268(1), 134-140. https://doi.org/10.1111/j.1749-6632.2012.06753.x

Intra-arterial vasodilator use during endovascular therapy for acute ischemic stroke might improve reperfusion rate. / El-Zammar, Ziad M K; Latorre, Julius Gene S; Wang, Dongliang; Satyan, Shyama; Elnour, Elwaleed; Kamel Elsayed Elokda, Adham; Devasenapathy, Ashok; Lodi, Yahia M.

In: Annals of the New York Academy of Sciences, Vol. 1268, No. 1, 09.2012, p. 134-140.

Research output: Contribution to journalArticle

El-Zammar, ZMK, Latorre, JGS, Wang, D, Satyan, S, Elnour, E, Kamel Elsayed Elokda, A, Devasenapathy, A & Lodi, YM 2012, 'Intra-arterial vasodilator use during endovascular therapy for acute ischemic stroke might improve reperfusion rate', Annals of the New York Academy of Sciences, vol. 1268, no. 1, pp. 134-140. https://doi.org/10.1111/j.1749-6632.2012.06753.x
El-Zammar, Ziad M K ; Latorre, Julius Gene S ; Wang, Dongliang ; Satyan, Shyama ; Elnour, Elwaleed ; Kamel Elsayed Elokda, Adham ; Devasenapathy, Ashok ; Lodi, Yahia M. / Intra-arterial vasodilator use during endovascular therapy for acute ischemic stroke might improve reperfusion rate. In: Annals of the New York Academy of Sciences. 2012 ; Vol. 1268, No. 1. pp. 134-140.
@article{d746c86b10294692a7c8b9b39b0e740b,
title = "Intra-arterial vasodilator use during endovascular therapy for acute ischemic stroke might improve reperfusion rate",
abstract = "Treatment of acute ischemic stroke (AIS) is an evolving field. New treatment options are still needed in order to achieve greater success rates for arterial recanalization. Intra-arterial therapy (lAT) is an option for AIS patients who are not good candidates for intravenous (i.v.) recombinant tissue plasminogen activator (rt-PA) or where it has failed. While good data establishing the role of IAT in AIS management are lacking, the potential clinical efficacy of IAT is based on the premise that recanalization and reperfusion may result in better clinical outcome. Although lAT recanalization and reperfusion rates of large vessel occlusion are much higher than they are for i.v. rt-PA, IAT's radiological efficacy is still far from perfect. Vasodilator use during IAT for AIS may increase the recanalization and reperfusion rates of such therapy. In this report, we describe the radiographic and clinical outcomes in a cohort of AIS patients who received intra-arterial (i.a.) vasodilators during IAT and summarize the role of i.a. vasodilators in the process of recanalization and reperfusion.",
keywords = "Acute ischemic stroke, Endovascular, Fibrinolysis, Intra-arterial, Vasdodilators",
author = "El-Zammar, {Ziad M K} and Latorre, {Julius Gene S} and Dongliang Wang and Shyama Satyan and Elwaleed Elnour and {Kamel Elsayed Elokda}, Adham and Ashok Devasenapathy and Lodi, {Yahia M.}",
year = "2012",
month = "9",
doi = "10.1111/j.1749-6632.2012.06753.x",
language = "English (US)",
volume = "1268",
pages = "134--140",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Intra-arterial vasodilator use during endovascular therapy for acute ischemic stroke might improve reperfusion rate

AU - El-Zammar, Ziad M K

AU - Latorre, Julius Gene S

AU - Wang, Dongliang

AU - Satyan, Shyama

AU - Elnour, Elwaleed

AU - Kamel Elsayed Elokda, Adham

AU - Devasenapathy, Ashok

AU - Lodi, Yahia M.

PY - 2012/9

Y1 - 2012/9

N2 - Treatment of acute ischemic stroke (AIS) is an evolving field. New treatment options are still needed in order to achieve greater success rates for arterial recanalization. Intra-arterial therapy (lAT) is an option for AIS patients who are not good candidates for intravenous (i.v.) recombinant tissue plasminogen activator (rt-PA) or where it has failed. While good data establishing the role of IAT in AIS management are lacking, the potential clinical efficacy of IAT is based on the premise that recanalization and reperfusion may result in better clinical outcome. Although lAT recanalization and reperfusion rates of large vessel occlusion are much higher than they are for i.v. rt-PA, IAT's radiological efficacy is still far from perfect. Vasodilator use during IAT for AIS may increase the recanalization and reperfusion rates of such therapy. In this report, we describe the radiographic and clinical outcomes in a cohort of AIS patients who received intra-arterial (i.a.) vasodilators during IAT and summarize the role of i.a. vasodilators in the process of recanalization and reperfusion.

AB - Treatment of acute ischemic stroke (AIS) is an evolving field. New treatment options are still needed in order to achieve greater success rates for arterial recanalization. Intra-arterial therapy (lAT) is an option for AIS patients who are not good candidates for intravenous (i.v.) recombinant tissue plasminogen activator (rt-PA) or where it has failed. While good data establishing the role of IAT in AIS management are lacking, the potential clinical efficacy of IAT is based on the premise that recanalization and reperfusion may result in better clinical outcome. Although lAT recanalization and reperfusion rates of large vessel occlusion are much higher than they are for i.v. rt-PA, IAT's radiological efficacy is still far from perfect. Vasodilator use during IAT for AIS may increase the recanalization and reperfusion rates of such therapy. In this report, we describe the radiographic and clinical outcomes in a cohort of AIS patients who received intra-arterial (i.a.) vasodilators during IAT and summarize the role of i.a. vasodilators in the process of recanalization and reperfusion.

KW - Acute ischemic stroke

KW - Endovascular

KW - Fibrinolysis

KW - Intra-arterial

KW - Vasdodilators

UR - http://www.scopus.com/inward/record.url?scp=84866563945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866563945&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.2012.06753.x

DO - 10.1111/j.1749-6632.2012.06753.x

M3 - Article

VL - 1268

SP - 134

EP - 140

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -